Merit Medical Systems, Inc. (MMSI)
Merit Medical Stock Slips Despite the Launch of New Ventrax System
MMSI launches the Ventrax Delivery System, enhancing pulmonary access procedures with improved control, precision, and efficiency for interventionalists.
Merit Medical (MMSI) Surges 8.3%: Is This an Indication of Further Gains?
Merit Medical (MMSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
Merit Medical's strong product portfolio raises optimism about the stock.
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results
MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.
Merit Medical: A Success Story That Keeps Getting Better
Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and positive clinical data. The company's Wrapsody stent graft showed almost best-case clinical efficacy, positioning it to capture significant market share in dialysis graft occlusion procedures. Recent acquisitions, including EsophyX Z+ and Cook Medical's lead management portfolio, enhance Merit's product portfolio and offer longer-term synergies.
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.
Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.81 per share a year ago.
Gear Up for Merit Medical (MMSI) Q4 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Merit Medical (MMSI) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
